Ramsey has made just six Premier League appearances this campaign due to a recurring hamstring problem, while Welbeck has yet to feature in 2016-17 due to a knee injury. Both are on their way back, though, much to Wenger’s satisfaction. [ WENGER: OZIL WILL RESPOND ON THE PITCH ] “I don’t know yet whether Ramsey will be involved against West Brom on Monday, but he will be back in training on Friday,” the Arsenal boss said at a news conference. “He is efficient offensively. He is highly active. Ramsey is a complete box-to-box player, gives usoptions, almost like a new signing because he has not played many games. “But let’s not be premature and wait how things go. He had some setbacks, but we hope he will be alright this time. “There is also good news regarding Welbeck. view publisher siteHe will train for the first time again on Friday. “But he will need some time. It is like the start of a new career for him after so much time out. But I am even more cautious with Welbeck than with Ramsey.” Meanwhile, Alex Oxlade-Chamberlain’shamstring injury is not as bad as first feared, whileShkodran Mustafi remains unavailable with a similar issue.
For the original version including any supplementary images or video, visit http://sports.yahoo.com/news/wenger-cautious-welbeck-ramsey-100738952.html
Effective July 31, 2015, TiGenix acquired Coretherapix, whose lead cellular product candidate, AlloCSC-01, is currently in a Phase II clinical trial in Acute Myocardial Infarction (AMI). https://www.youtube.com/watch?feature=player_embedded&v=Pf7JuJcVzQUIn addition, the second product candidate from the cardiac stem cell-based platform acquired from Coretherapix, AlloCSC-02, is being developed in a chronic indication. On July 4, 2016, TiGenix entered into a licensing agreement with Takeda, a large pharmaceutical company active in gastroenterology, under which Takeda acquired the exclusive right to commercialize Cx601 for complex perianal fistulas outside the United States. TiGenix is headquartered in Leuven (Belgium) and has operations in Madrid (Spain). Forward-looking information This press release may contain forward-looking statements and estimates with respect to the anticipated future performance of TiGenix and the market in which it operates. Certain of these statements, forecasts and estimates can be recognised by the use of words such as, without limitation, “believes”, “anticipates”, “expects”, “intends”, “plans”, “seeks”, “estimates”, “may”, “will” and “continue” and similar expressions. They include all matters that are not historical facts. Such statements, forecasts and estimates are based on various assumptions and assessments of known and unknown risks, uncertainties and other factors, which were deemed reasonable when made but may or may not prove to be correct. Actual events are difficult to predict and may depend upon factors that are beyond TiGenix’s control.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/takeda-makes-10-million-equity-210502767.html
Your flutes are crying out for some attention in the gym. Varsity Coach Position-Specific training“Varsity Vision” “Varsity Vision” is designed to be conducted at the council, district, or chartered organization level. It’s a master class in building bad ass mass. Build better belts with this volume-packed workout from fitness model Samantha Leete! After each section of material, you will answer questions about that section’s topic. REGISTER NOW FOR THE January 2016 Florida SEA BASE VOLUNTEER DEVELOPMENT CONFERENCES LOOK UNDER QUICKLINKS ON THIS PAGE! Open to both registered adults and youth who are at least 13 and have completed the 8th grade, Powder Horn is a hands-on resource management course designed to give you the contacts and tools necessary to conduct an awesome high-adventure program in your troop, team, crew, or ship. This presentation provides a detailed briefing for individuals selected to serve as a camp health officer at a council or district camping facility.